Company Profile
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest News
| Sector | Industrials |
| Industry | Specialty Business Services |
| Website | https://www.relx.com |
| Audit Risk | 1 |
| Board Risk | 3 |
| Overall Risk | 2 |
| Market Cap | 46.06B |
| Trailing P/E | 21.1 |
| Forward P/E | 16.79 |
| Dividend Rate | 0.69 |
| Dividend Yield | 2.68% |
| Trailing Annual Div. Rate | 0.69 |
| Trailing Annual Div. Yield | 0.03% |
| Trailing EPS | 1.25 |
| Forward EPS | 1.57 |
| Book Value | 0.71 |
| Price-to-Book | 3,724.58 |
| Enterprise-to-Revenue | 5.52 |
| Enterprise-to-EBITDA | 16.29 |
| Ex-Dividend Date | 08/06/2026 |
| Earnings Date | 07/23/2026 |
| Earnings Call Date | 07/23/2026 |